Research Article
Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients
Table 3
Clinical and biochemical characteristics of the diabetic patients.
| | NVD | VD | |
| | | | | Male Sex (%) | | | |
| | Average +/− SD | Average +/− SD | value | Age | 56.2 +/− 2.3 | 60.8 +/− 1.4 | 0.070 | BMI | 31.0 +/−1.3 | 29.7 +/− 0.8 | 0.036 | Total protein (g/L) | 71.1 +/− 4.8 | 70.3 +/− 4.4 | 0.369 | Albuminemia (g/L) | 41.9 +/− 2.8 | 42.5 +/− 2.8 | 0.156 | Fructosamine (mol/g) | 4.68 +/− 0.78 | 4.84 +/− 0.77 | 0.392 | HbA1c (%) | 8.9 +/− 0.2 | 9.1 +/− 0.2 | 0.31 | Glycemia (mmol/L) | 9.0 +/− 2.9 | 9.2 +/− 3.1 | 0.754 | Total cholesterol (mmol/L) | 4.17 +/− 0.84 | 4.11 +/− 1.17 | 0.807 | HDL-cholesterol (mmol/L) | 1.13 +/− 0.30 | 1.12 +/− 0.28 | 0.882 | LDL-cholesterol (mmol/L) | 2.49 +/− 0.79 | 2.52 +/− 0.97 | 0.887 | Triglycerides (mmol) | 1.34 (0.99–1.77) | 1.49 (0.99–1.91) | 0.520 | (25–75th percentile) | | | | ApoA (mmol/L) | 1.30 +/− 0.22 | 1.30 +/− 0.22 | 1.000 | ApoB (mmol/L) | 0.89 +/− 0.21 | 0.88 +/− 0.28 | 0.866 | Urine protein (g/L) | 0.09 (0.06–0.13) | 0.10 (0.07–0.16) | 0.370 | (25–75th percentile) | Microalbuminuria (mg/L) | 63.1 +/− 153.2 | 83.5 +/− 192.5 | 0.606 |
|
|
The panel of diabetic patients is divided into two groups: diabetic patients with and without vascular disease (resp., VD, , and NVD, ).
|